Dashboard
Manage Tickers

RPRX


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

stocks-rebound-eli-lilly-jumps-to-14-month-highs-whats-moving-markets-wednesday
Stocks Rebound, Eli Lilly Jumps To 14-Mont...
11/05/2025 18:23:55

Wall Street bounced back Wednesday after Tuesday's sharp selloff in AI-driven stocks, as investors bought the dip amid soli...

royalty-pharma-q3-adj-eps-117-beats-104-estimate-sales-609000m-miss-739257m-estimate
Royalty Pharma Q3 Adj. EPS $1.17 Beats $1....
11/05/2025 12:03:36

Royalty Pharma (NASDAQ:RPRX) reported quarterly earnings of $1.17 per share which beat the analyst consensus estimate of $1.04 ...

earnings-scheduled-for-november-5-2025
Earnings Scheduled For November 5, 2025
11/05/2025 11:12:12

Core News & Articles
Royalty Pharma Acquires Royalty Interest I...
11/04/2025 12:18:09

Royalty Pharma plc (NASDAQ:RPRX) today announced that it has acquired a royalty interest in Alnylam's AMVUTTRA from funds m...

morgan-stanley-maintains-overweight-on-royalty-pharma-lowers-price-target-to-54
Morgan Stanley Maintains Overweight on Roy...
10/10/2025 17:40:39

Morgan Stanley analyst Terence Flynn maintains Royalty Pharma (NASDAQ:RPRX) with a Overweight and lowers the price target fr...

goldman-sachs-initiates-coverage-on-royalty-pharma-with-buy-rating-announces-price-target-of-42
Goldman Sachs Initiates Coverage On Royalt...
09/30/2025 13:03:42

Goldman Sachs analyst Asad Haider initiates coverage on Royalty Pharma (NASDAQ:RPRX) with a Buy rating and announces Price ...

how-do-investors-really-feel-about-royalty-pharma
How Do Investors Really Feel About Royalty...
09/16/2025 20:00:50

royalty-pharma-guides-for-47b-portfolio-receipts-and-4b-cash-flow-by-2030-exceeding-analyst-estimates
Royalty Pharma Guides For $4.7B Portfolio ...
09/11/2025 11:03:52

Royalty Pharma plc (NASDAQ:RPRX) will host an Investor Day in New York City today. Senior executives will provide an update on ...

reported-earlier-royalty-pharma-prices-2b-senior-unsecured-notes-offering-with-600m-due-2031-at-4450-900m-due-2035-at-5200-and-500m-due-2055-at-5950
Reported Earlier, Royalty Pharma Prices $2...
09/03/2025 06:49:24

Core News & Articles
Royalty Pharma To Provide Up To $300M In F...
09/02/2025 11:10:11

beone-cashes-in-on-amgens-cancer-drug-royalties-in-multibillion-dollar-pharma-tie-up
BeOne Cashes In On Amgen's Cancer Drug Roy...
08/25/2025 17:19:29

BeOne Medicines will sell global Imdelltra royalties to Royalty Pharma for up to $950 million while retaining rights to other o...

Core News & Articles
BeOne Medicines Agrees To Sell Its Royalty...
08/25/2025 10:07:02

Under the terms of the agreement, BeOne will receive an upfront payment of $885 million, with the option to sell remaining roya...

heres-how-much-1000-invested-in-royalty-pharma-15-years-ago-would-be-worth-today
Here's How Much $1000 Invested In Royalty ...
08/12/2025 14:00:22

royalty-pharma-q2-adj-eps-114-beats-108-estimate-sales-579000m-miss-666745m-estimate
Royalty Pharma Q2 Adj. EPS $1.14 Beats $1....
08/06/2025 11:02:35

Royalty Pharma (NASDAQ:RPRX) reported quarterly earnings of $1.14 per share which beat the analyst consensus estimate of $1.08 ...

Core News & Articles
Earnings Scheduled For August 6, 2025
08/06/2025 08:33:21

citigroup-maintains-buy-on-royalty-pharma-raises-price-target-to-42
Citigroup Maintains Buy on Royalty Pharma,...
07/22/2025 12:57:25

Citigroup analyst Geoff Meacham maintains Royalty Pharma (NASDAQ:RPRX) with a Buy and raises the price target from $40 to $42.

morgan-stanley-maintains-overweight-on-royalty-pharma-raises-price-target-to-54
Morgan Stanley Maintains Overweight on Roy...
07/10/2025 16:17:04

Morgan Stanley analyst Terence Flynn maintains Royalty Pharma (NASDAQ:RPRX) with a Overweight and raises the price target fr...

if-you-invested-1000-in-this-stock-10-years-ago-you-would-have-this-much-today
If You Invested $1000 In This Stock 10 Yea...
07/09/2025 15:00:20

revolution-medicines-to-advance-lead-cancer-drug-with-2-billion-in-funds
Revolution Medicines To Advance Lead Cance...
06/24/2025 18:35:32

Revolution Medicines signs a $2 billion funding deal with Royalty Pharma to support its RAS(ON) pipeline, including daraxonrasi...

Core News & Articles
Revolution Medicines Secures $2B Flexible ...
06/24/2025 13:57:03

Flexible funding provides $2 billion in committed capital comprised of up to $1.25 billion of synthetic royalty and up to $750 ...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION